Tattoo removal cream licensed to Cipher

Guest Contributor
May 4, 2016

A topical tattoo removal cream developed by a PhD student at Dalhousie Univ has been licenced to Cipher Pharmaceuticals Inc, a Mississauga-based specialty pharmaceutical dermatology company. Alec Falkenham's investigational cream des-troys macrophages (white blood cells) that hold tattoo inks, resulting in a faded or eliminated tattoo. The cream is seen as an alternative to costly and painful laser treatments. The agreement was facilitated by Dalhousie's industry liaison and innovation office and Cipher plans to commercialize the cream. It's estimated that one in eight Americans with tattoos reg


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.